FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075182 [Registered on: 14/10/2024] Trial Registered Prospectively
Last Modified On: 12/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   Effect of Serum Cortisol Levels on Reversal of Shock in Adults with Septic Shock. 
Scientific Title of Study   Effect of Serum Cortisol Levels on Reversal of Shock in Adults with Septic Shock- A Prospective Observational Study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Senthilnathan M 
Designation  Associate Professor 
Affiliation  Autonomous institution 
Address  Department of Anaesthesiology and Critical care, Room no.27 Jipmer campus road, Gorimedu,Dhanvantari Nagar,Puducherry.

Pondicherry
PONDICHERRY
605006
India 
Phone  7598566983  
Fax    
Email  mmc.senthil@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ujjaini Pandi 
Designation  Student 
Affiliation  Autonomous institution 
Address  Department of Anaesthesiology and Critical care, JIPMER campus road,Gorimedu,Dhanvantari Nagar,Puducherry

Pondicherry
PONDICHERRY
605006
India 
Phone  9500421367  
Fax    
Email  ujjaini.pandi@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Senthilnathan M 
Designation  Associate Professor 
Affiliation  Autonomous institution 
Address  Department of Anaesthesiology, JIPMER Campus road,Gorimedu,Dhanvantari Nagar,Puducherry


PONDICHERRY
605006
India 
Phone  7598566983  
Fax    
Email  mmc.senthil@gmail.com  
 
Source of Monetary or Material Support  
Intra Mural Research Fund,JIPMER,puducherry,India-605006. 
 
Primary Sponsor  
Name  Dr DMThappaIntra Mural Research FundJIPMER 
Address  Jipmer campus road,Gorimedu, Dhanvantari Nagar, Pondicherry-605006 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Senthilnathan M  JIPMER CCU  Department of Anaesthesiology and Critical Care,Jipmer campus road,Gorimedu, Dhanvantari Nagar, Pondicherry-605006
Pondicherry
PONDICHERRY 
7598566983

mmc.senthil@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Instituitional Ethics Commitee for Observational Studies,JIPMER  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D899||Disorder involving the immune mechanism, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Adults with septic shock requiring high vasopressor therapy to
maintain MAP of ≥ 65 mmHg for more than one hour, despite
adequate fluid therapy. 
 
ExclusionCriteria 
Details  1.H/o Hypothalamic-pituitary-adrenal axis dysfunction
2.H/o Glucocorticoid/estrogen therapy
3. Patients with autoimmune disorders
4. Pregnancy
5. H/o drug intake that influence HPA axis response.
(Eg: ketoconazole). 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To compare the proportion of patients develops reversal of shock between responders
and non-responders. 
Time to reversal of shock,28 day mortality benefit. 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the 28 days mortality between critically ill septic shock adults between responders and non-responders.
To compare the length of ICU stay between critically ill septic shock adults between responders and non-responders.
To compare the need for RRT between critically ill septic shock adults be-tween responders and non-responders.
 
28 days of mechanical ventilator free days. 
 
Target Sample Size   Total Sample Size="180"
Sample Size from India="180" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   23/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  23/10/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Administration of steroid therapy in patients with sepsis who have normal/high serum
cortisol level may be deleterious as the steroid can worsen the ongoing infection. This
study has been designed to study the effect of hydrocortisone on outcomes of septic
shock adults with normal/high serum cortisol.
 
Close